Gelex

Corrigendum to the Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 August 2016 to 31 August 2016 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council) (Official Journal of the European Union C 362 of 30 September 2016) 2017/C 447/03

Version 2016-08-01
Grade B

mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.

Ask Gelex about this law

Address https://gelex.eu/eli/EU/corrigendum/oj/C/2017/447/03@2016-08-01/en

Contents
  1. for:read:

for:read:

On page 9: Withdrawal of a marketing authorization (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council), Suspension of a marketing authorization (Article 45 of Regulation (EC) No 726/2004 of the European Parliament and of the Council).

Versions

  1. 2016-08-01